These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5442574)

  • 1. The effect of oral phosphate upon the urinary excretion of oxalic acid.
    Elliot JS; Ribeiro ME; Eusebio E
    Invest Urol; 1970 May; 7(6):528-31. PubMed ID: 5442574
    [No Abstract]   [Full Text] [Related]  

  • 2. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis.
    Takasaki E; Shimano E
    Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639
    [No Abstract]   [Full Text] [Related]  

  • 3. [The urinary excretion of oxalic acid in urolithiasis. 3. Oxalic acid in concentrated urine].
    Takasaki E
    Nihon Hinyokika Gakkai Zasshi; 1971 Aug; 62(8):63-7. PubMed ID: 5106460
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary oxalic acid excretion differs after oral loading of rats with various oxalate salts.
    Hossain RZ; Ogawa Y; Morozumi M; Sugaya K; Hatano T
    Int J Urol; 2003 Jan; 10(1):43-8. PubMed ID: 12534926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The urinary excretion of oxalic acid in urolithiasis. II. The relationship of oxalic acid and electrolytes in urine].
    Takasaki E; Shimano E
    Nihon Hinyokika Gakkai Zasshi; 1967 Feb; 58(2):210-6. PubMed ID: 6069875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary excretion of calcium, magnesium, phosphates, oxalates and urates in normal children en Switzerland].
    Matos V; Melle GV; Markert M; Guignard JP
    Rev Med Suisse Romande; 1996 Oct; 116(10):839-43. PubMed ID: 8966463
    [No Abstract]   [Full Text] [Related]  

  • 7. [The excretion of oxalates in urine following oral administration of oxalic acid and magnesium].
    Berg W; Schneider HJ; Vogel E
    Dtsch Z Verdau Stoffwechselkr; 1975; 35(5):241-5. PubMed ID: 1225513
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of dietary factors on the risk of urinary stone formation.
    Hesse A; Siener R; Heynck H; Jahnen A
    Scanning Microsc; 1993 Sep; 7(3):1119-27; discussion 1127-8. PubMed ID: 8146611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of oxaluria in the genesis and in the dietetics of the oxalica lithiasis].
    Cottet J; Vittu C; Lemahieu JC
    Clin Ter; 1968 Jan; 44(1):3-24. PubMed ID: 4903975
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Acta Chir Scand; 1983; 149(1):93-8. PubMed ID: 6837229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of magnesium sulphate on the absorption, excretion and retention of calcium and phosphorus by sheep fed on phosphate supplemented rations.
    Myburgh SJ; Du Toit Jde V
    Onderstepoort J Vet Res; 1970 Mar; 37(1):1-5. PubMed ID: 5526335
    [No Abstract]   [Full Text] [Related]  

  • 14. Excretion of urinary phosphate and magnesium on three diets in patients with urolithiasis.
    Juuti M; Alhava EM; Lammi S
    Ann Clin Res; 1981 Feb; 13(1):1-5. PubMed ID: 7247320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
    Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
    J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic phosphate treatment of nephrolithiasis.
    Ettinger B; Kolb FO
    Am J Med; 1973 Jul; 55(1):32-7. PubMed ID: 4715930
    [No Abstract]   [Full Text] [Related]  

  • 17. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative effects of oral water load of different mineral compositions on the excretion of ions and oxalic acid].
    Vanherweghem JL; Quenon M; Dhaene M; Goldman M; Philippart Y; Stolear JC; Thayse C; Waterlot Y
    Nephrologie; 1984; 5(4):184-8. PubMed ID: 6527722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of some drugs on oxalic acid excretion in urine.
    el-Dakhakhny M; el-Sayed M
    Arzneimittelforschung; 1970 Feb; 20(2):264-7. PubMed ID: 4392557
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.
    Subha K; Varalakshmi P
    Biochem Mol Biol Int; 1993 Feb; 29(2):271-80. PubMed ID: 7684293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.